Mobile

A Phase 2, Multicenter, Open-Label Extension (OLE) Study to Observe the Long-Term Efficacy, Safety, and Tolerability of Repeated Administration of ABT 494 in Subjects with Crohn's Disease

Update Il y a 4 ans
Reference: EUCTR2015-003759-23

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

To observe the long-term efficacy, safety, and tolerability of repeated administration of ABT-494 in subjects with Crohn's disease (CD) who completed Study M13-740.

Inclusion criteria

  • Crohn’s Disease

Links